非奈利酮在哪里能买到

Where to buy fenelidone

Fenelidone was approved for marketing by the State Food and Drug Administration on June 29, 2022, which means that Fenelidone has begun to be sold in domestic hospital pharmacies. In other words, patients can purchase fenelidone in domestic hospital pharmacies. Fennelidone is used in adult patients with chronic kidney disease associated with type 2 diabetes to reduce the risk of sustained decline in eGFR (glomerular filtration rate) and end-stage renal disease. However, due to the large gap in imported drugs, it is not easy for patients to purchase them.

Where can I buy fenelidone that is available overseas?

Fenelidone was approved for marketing by the US FDA in July 2021, and in December of the same year, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use approved the drug's marketing application. If patients want to buy fenelidone that is marketed overseas, they need to go to countries where it is already on the market. The journey is long, the risk is high, and the cost is high. At this time, patients can also obtain fenelidone through domestic professional overseas medical service institutions, which can be directly mailed to their homes from overseas pharmacies. This ensures that the drug is genuine and affordable, making it more suitable for patients to take the drug for a long time.

Is there a generic version of fenelidone?

There is currently no generic version of fenelidone. Since fenelidone has just been launched not long ago and the original drug is still under patent protection, there is currently no news of generic drugs being launched. Patients in need can obtain Bayer's fenelidone from Germany through domestic professional overseas medical service institutions, which can save patients the trouble of purchasing drugs abroad. However, overseas drugs are affected by exchange rate fluctuations and the price is not fixed. For more details, please consult the medical companion and passenger service staff.

Fenelidone has the effect of delaying the progression of chronic kidney disease. It is a new type of mineralocorticoid receptor antagonist that can be used for the treatment of diabetic nephropathy, chronic kidney disease and end-stage renal disease. Fenelidone is a third-generation mineralocorticoid receptor antagonist that has just been released after spironolactone and eplerenone. It is recommended that patients take medication under the guidance of a doctor and not use it blindly.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: